Extra-epitopic hepatitis C virus polymorphisms confer resistance to broadly neutralizing antibodies by modulating binding to scavenger receptor B1

Broadly-neutralizing monoclonal antibodies (bNAbs) may guide vaccine development for highly variable viruses including hepatitis C virus (HCV), since they target conserved viral epitopes that could serve as vaccine antigens. However, HCV resistance to bNAbs could reduce the efficacy of a vaccine. HC...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:PLoS Pathog
Autors principals: El-Diwany, Ramy, Cohen, Valerie J., Mankowski, Madeleine C., Wasilewski, Lisa N., Brady, Jillian K., Snider, Anna E., Osburn, William O., Murrell, Ben, Ray, Stuart C., Bailey, Justin R.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342271/
https://ncbi.nlm.nih.gov/pubmed/28235087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.ppat.1006235
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars